Interpretation of Mixture model in NT
Assembled By :
Nilou Lab
Latest Update:
2020/05/18
Interpretation of Mixture model in NT
1- The distribution in which NT increases with CRL:
is the same for chromosomally abnormal and euploid fetuses but the proportion that follows this distribution is :
- - large in the euploid group (about 95%)
- - and small in the abnormal group being about 5%, 30%, 15% and 20% for trisomies 21, 18, 13 and Turner syndrome, respectively.
2- The distribution in which NT does not change with CRL :
is firstly, small for euploid fetuses and large for the abnormal group
and secondly, the median NT is different,
- - being 2.0 mm for the euploid group
- - and 3.4 mm for trisomies 21,
- - 5.5 mm for trisomies 18,
- - 4.0 mm for trisomies 13,
- - and 9.2 mm for Turner syndrome.
1- The distribution in which NT increases with CRL:
is the same for chromosomally abnormal and euploid fetuses but the proportion that follows this distribution is :
- - large in the euploid group (about 95%)
- - and small in the abnormal group being about 5%, 30%, 15% and 20% for trisomies 21, 18, 13 and Turner syndrome, respectively.
2- The distribution in which NT does not change with CRL :
is firstly, small for euploid fetuses and large for the abnormal group
and secondly, the median NT is different,
- - being 2.0 mm for the euploid group
- - and 3.4 mm for trisomies 21,
- - 5.5 mm for trisomies 18,
- - 4.0 mm for trisomies 13,
- - and 9.2 mm for Turner syndrome.
Other Article
-
Launch of the first FDA-approved technology in Iran to diagnose HPV (updated)
-
Errors in POCT (Point of Collection Testing) and alternative site testing
-
First-Trimester Contingent Screening for Trisomy 21 by Fetal Nuchal Translucency and Maternal Serum Biomarkers and Maternal Blood Cell-Free DNA Testing
-
Human papilloma virus (HPV) genotypes concordance between Iranian couples referrals
-
Some Points about Serum biochemistry in prenatal screening
-
Some points about the Nuchal Translucency in Ultrasound according to FMF
-
Non-invasive prenatal test to screen common trisomies in twin pregnancies
-
New Findings on the Use of Fibrinogen in Gynecological Diseases
-
Fine-tuning of routine combined first- trimester screening
-
The decision to discontinue home isolation should be made in the context of local circumstances.